4lp0
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | {{STRUCTURE_4lp0| PDB=4lp0 | SCENE= }} | |
+ | ===Crystal structure of a topoisomerase ATP inhibitor=== | ||
+ | {{ABSTRACT_PUBMED_24098982}} | ||
- | + | ==About this Structure== | |
+ | [[4lp0]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LP0 OCA]. | ||
- | + | ==Reference== | |
- | + | <ref group="xtra">PMID:024098982</ref><references group="xtra"/><references/> | |
- | + | [[Category: Basarab, G S.]] | |
+ | [[Category: Bist, S.]] | ||
+ | [[Category: Boriack-Sjodin, P A.]] | ||
+ | [[Category: Dangel, B.]] | ||
+ | [[Category: Eakin, A E.]] | ||
+ | [[Category: Illingsworth, R.]] | ||
+ | [[Category: Manchester, J I.]] | ||
+ | [[Category: Sherer, B A.]] | ||
+ | [[Category: Sriram, S.]] | ||
+ | [[Category: Uria-Nickelsen, M.]] | ||
+ | [[Category: Antimicrobial]] | ||
+ | [[Category: Atp binding]] | ||
+ | [[Category: Atpase domain]] | ||
+ | [[Category: Isomerase-isomerase inhibitor complex]] | ||
+ | [[Category: Protein-inhibitor complex]] | ||
+ | [[Category: Structure-based drug design]] | ||
+ | [[Category: Virtual screen]] |
Revision as of 08:19, 13 November 2013
Crystal structure of a topoisomerase ATP inhibitor
Template:ABSTRACT PUBMED 24098982
About this Structure
4lp0 is a 1 chain structure. Full crystallographic information is available from OCA.
Reference
- Basarab GS, Manchester JI, Bist S, Boriack-Sjodin PA, Dangel B, Illingworth R, Sherer BA, Sriram S, Uria-Nickelsen M, Eakin AE. Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents. J Med Chem. 2013 Oct 29. PMID:24098982 doi:http://dx.doi.org/10.1021/jm401208b
Categories: Basarab, G S. | Bist, S. | Boriack-Sjodin, P A. | Dangel, B. | Eakin, A E. | Illingsworth, R. | Manchester, J I. | Sherer, B A. | Sriram, S. | Uria-Nickelsen, M. | Antimicrobial | Atp binding | Atpase domain | Isomerase-isomerase inhibitor complex | Protein-inhibitor complex | Structure-based drug design | Virtual screen